BioDue S.p.A. Stock price

Equities

BIO2

IT0005108730

Pharmaceuticals

Delayed Borsa Italiana 5-day change 1st Jan Change
- EUR -.--% Intraday chart for BioDue S.p.A. -.--% -.--%
Sales 2017 35.9M 38.74M Sales 2018 41.5M 44.77M Capitalization 56.19M 60.63M
Net income 2017 4M 4.32M Net income 2018 3M 3.24M EV / Sales 2017 1.85 x
Net Debt 2017 5.9M 6.36M Net Debt 2018 10.55M 11.38M EV / Sales 2018 1.61 x
P/E ratio 2017
14.7 x
P/E ratio 2018
14.1 x
Employees -
Yield 2017
1.11%
Yield 2018
1.98%
Free-Float 20.71%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 86-01-01
Director/Board Member 49 11-01-09
Director/Board Member 59 10-05-02
Members of the board TitleAgeSince
Chief Executive Officer 55 86-01-01
Director/Board Member 59 10-05-02
Director/Board Member 38 09-12-31
More insiders
BioDue SpA is an Italy-based consolidated industrial and commercial enterprise oriented towards the research, development, production and commercialization of cosmetic products, medical devices and food supplements, both liquid and solid. It manages almost its entire supply chain from raw materials to the research and development of formulations, right up to the production and relative commercialization of products throughout the world. The Company is structured around two divisions with specific competencies: Contract Manufacturing and Brand Owner. Contract Manufacturing is entirely dedicated to the manufacture of third party brand solid and liquid food supplements, cosmetics and medical devices. Brand Owner manufactures and commercializes own-brand dermatological, ophthalmic products and food supplements under the brands Pharcos, Biofta, Selerbe.
More about the company
  1. Stock
  2. Equities
  3. Stock BioDue S.p.A. - Borsa Italiana